Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2016 Filed May 26, 2017 17:23 UTC |
SULLIVAN LOUIS WDirector
|
OtherCommon Stock | 577 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022461 · doc1.xml · nonDerivative · entry 3 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,818 F3 · security: In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:23 UTC |
SULLIVAN LOUIS WDirector
|
OtherCommon Stock | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022461 · doc1.xml · nonDerivative · entry 2 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,241 F2 · security: In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017 and May 2018. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:23 UTC |
SULLIVAN LOUIS WDirector
|
OtherCommon Stock | 152 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022461 · doc1.xml · nonDerivative · entry 1 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,637 F1 · security: In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017. Read SEC document |
| August 01, 2016 Filed May 26, 2017 18:18 UTC |
Harsanyi ZsoltDirector
|
OtherEmployee Stock Option (Right to buy) · Derivative | 301 | $0.00 Strike: $18.64 | $0.00 |
DisclosureSEC source: 0001140361-17-022490 · doc1.xml · derivative · entry 5 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,434 Underlying: Common Stock · 3,434 shares Expires 2021-05-21 F6 · security: Consists of an option granted on May 22, 2014 under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F7 · derivative.exercise_date: In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of stock options as a result of an adjustment to an existing Emergent stock option grant held by the reporting person prior to the Spin-off. The stock options vest in May 2017. Read SEC document |
| August 01, 2016 Filed May 26, 2017 18:18 UTC |
Harsanyi ZsoltDirector
|
OtherCommon Stock | 577 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022490 · doc1.xml · nonDerivative · entry 3 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,818 F3 · security: In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019. Read SEC document |
| August 01, 2016 Filed May 26, 2017 18:18 UTC |
Harsanyi ZsoltDirector
|
OtherCommon Stock | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022490 · doc1.xml · nonDerivative · entry 2 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,241 F2 · security: In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017 and May 2018. Read SEC document |
| August 01, 2016 Filed May 26, 2017 18:18 UTC |
Harsanyi ZsoltDirector
|
OtherCommon Stock | 152 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022490 · doc1.xml · nonDerivative · entry 1 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,637 F1 · security: In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) (Common Stock) · Derivative | 905 | $0.00 Strike: $18.64 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 8 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,305 Underlying: Common Stock · 10,305 shares Expires 2021-05-22 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) (Common Stock) · Derivative | 693 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 7 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 7,893 shares Expires 2020-05-23 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) (Common Stock) · Derivative | 693 | $0.00 Strike: $13.37 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 6 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 7,893 shares Expires 2019-05-17 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) · Derivative | 693 | $0.00 Strike: $20.08 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 5 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 7,893 shares Expires 2021-05-19 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) · Derivative | 693 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 4 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 7,893 shares Expires 2020-05-20 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) · Derivative | 2,081 | $0.00 Strike: $10.64 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 3 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,681 Underlying: Common Stock · 23,681 shares Expires 2019-05-21 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| August 01, 2016 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
OtherEmployee Stock Option (Right to buy) · Derivative | 2,081 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · derivative · entry 2 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,681 Underlying: Common Stock · 23,681 shares Expires 2018-05-21 F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionStock Option · Derivative | 5,503 | $0.00 Strike: $29.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · derivative · entry 15 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,514 Underlying: Common Stock · 5,503 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Consists of an option granted under the company's stock incentive plan on March 10, 2015. F17 · derivative.exercise_date: The option vest in three equal installments in March 2016, 2017 and 2018. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionStock Option · Derivative | 17,354 | $0.00 Strike: $28.09 | $0.00 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · derivative · entry 14 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,708 Underlying: Common Stock · 17,354 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Consists of an option granted under the company's stock incentive plan on March 11, 2014. F16 · derivative.exercise_date: The option vest in three equal installments in March 2015, 2016 and 2017. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionStock Option · Derivative | 3,939 | $0.00 Strike: $14.67 | $0.00 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · derivative · entry 13 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,940 Underlying: Common Stock · 3,939 shares Expires 2020-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Consists of an option granted under the company's stock incentive plan on March 12, 2013. F15 · derivative.exercise_date: The option vest in three equal installments in March 2014, 2015 and 2016. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionStock Option · Derivative | 11,531 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · derivative · entry 12 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,531 Underlying: Common Stock · 11,531 shares Expires 2019-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan on November 5, 2012. F14 · derivative.exercise_date: The option vested in three equal installments in November 2013, 2014 and 2015. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 2,945 | $35.73 | $105,224.85 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 11 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,831 F10 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F13 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.32, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 1,855 | $35.80 | $66,409.00 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 10 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,776 F10 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F12 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.13, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 445 | $35.93 | $15,988.85 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 9 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,631 F10 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F11 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.00, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 5,503 | $35.66 | $196,236.98 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 8 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,076 F5 · security: Consists of an option granted under the company's stock incentive plan on March 10, 2015. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F9 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.12 to $36.42, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionCommon Stock | 5,503 | $29.00 | $159,587.00 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 7 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Consists of an option granted under the company's stock incentive plan on March 10, 2015. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 17,354 | $35.48 | $615,719.92 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 6 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,076 F4 · security: Consists of an option granted under the company's stock incentive plan on March 11, 2014. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.07 to $36.35, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionCommon Stock | 17,354 | $28.09 | $487,473.86 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 5 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Consists of an option granted under the company's stock incentive plan on March 11, 2014. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 3,939 | $35.74 | $140,779.86 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 4 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,076 F3 · security: Consists of an option granted under the company's stock incentive plan on March 12, 2013. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.37 to $36.32, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionCommon Stock | 3,939 | $14.67 | $57,785.13 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Consists of an option granted under the company's stock incentive plan on March 12, 2013. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
SaleCommon Stock | 11,531 | $35.49 | $409,235.19 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,076 F2 · security: Consists of an option granted under the company's stock incentive plan on November 5, 2012. F1 · kind: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $36.34, inclusive. Read SEC document |
| April 01, 2016 Filed Feb 24, 2017 15:05 UTC Amendment |
Kramer RobertEVP, Corporate Services Divisi
|
Exercise / conversionCommon Stock | 11,531 | $14.41 | $166,161.71 |
DisclosureSEC source: 0001140361-17-008973 · doc1.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · EVP, Corporate Services Divisi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan on November 5, 2012. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.